Andrew Brown

Andrew Brown has a diverse work experience spanning multiple roles and companies. Andrew is currently the Director of Drug Discovery Portfolio Marketing at Inotiv, where they are responsible for developing the marketing strategy and driving growth across different business units. Prior to this, Andrew served as the Director of Commercial Development - Services at Inotiv, where they focused on expanding the company's scientific services through sales to new and existing customers.

Before joining Inotiv, Andrew worked at Horizon Discovery as a Product Manager, where they played a key role in driving product and service innovation for the in vivo portfolio. Andrew also served as an Operations Manager at Horizon Discovery.

Earlier in their career, Andrew worked as an R&D Scientist at SAGE® Labs, a Research Associate at Monsanto, and a Senior Research Technician at Washington University School of Medicine in St. Louis.

Overall, Andrew's work experience showcases their expertise in marketing strategy, commercial development, product management, and scientific research.

Andrew Brown has a strong education history, beginning with their Bachelor of Science (B.S.) in Biology from the University of Arkansas, which they completed from 1996 to 2001. Andrew then pursued further education, earning a Master of Arts (M.A.) degree in Biology with an emphasis in Genetics from Washington University in St. Louis from 2004 to 2006. Later, they earned a Master of Business Administration (MBA) degree from Webster University between 2014 and 2016.